AU5041190A - Transdermal drug delivery composition - Google Patents

Transdermal drug delivery composition

Info

Publication number
AU5041190A
AU5041190A AU50411/90A AU5041190A AU5041190A AU 5041190 A AU5041190 A AU 5041190A AU 50411/90 A AU50411/90 A AU 50411/90A AU 5041190 A AU5041190 A AU 5041190A AU 5041190 A AU5041190 A AU 5041190A
Authority
AU
Australia
Prior art keywords
drug delivery
transdermal drug
delivery composition
composition
transdermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50411/90A
Other languages
English (en)
Inventor
Hui Ho-Wah
Fu Lu Mou-Ying
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU5041190A publication Critical patent/AU5041190A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/553—Renin inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU50411/90A 1989-01-24 1990-01-13 Transdermal drug delivery composition Abandoned AU5041190A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30131089A 1989-01-24 1989-01-24
US301310 1989-01-24

Publications (1)

Publication Number Publication Date
AU5041190A true AU5041190A (en) 1990-08-24

Family

ID=23162825

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50411/90A Abandoned AU5041190A (en) 1989-01-24 1990-01-13 Transdermal drug delivery composition

Country Status (6)

Country Link
KR (1) KR910700066A (ko)
AU (1) AU5041190A (ko)
GR (1) GR900100044A (ko)
IE (1) IE900245L (ko)
IL (1) IL93143A0 (ko)
WO (1) WO1990008553A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11684624B2 (en) 2009-06-24 2023-06-27 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
CN101875608B (zh) * 2010-05-31 2014-01-22 沈阳药科大学 一类香芹醇酯类衍生物及含有该衍生物的经皮吸收制剂
JP2014504592A (ja) 2010-12-29 2014-02-24 ストラテジック サイエンス アンド テクノロジーズ， エルエルシー 勃起不全および他の適応症の処置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7800762A (nl) * 1978-01-20 1979-07-24 Acf Chemiefarma Nv Vloeibare, voor injectie geschikte farmaceu- tische samenstellingen.
US4353896A (en) * 1981-06-08 1982-10-12 Levy Michael A Penetrating topical medicament
EP0127426A1 (en) * 1983-05-23 1984-12-05 Takeda Chemical Industries, Ltd. Percutaneous pharmaceutical compositions for external use
GR81250B (en) * 1983-12-22 1985-11-19 American Home Prod Menthol enhancement of transdermal drug delivery
JPS60149530A (ja) * 1984-01-13 1985-08-07 Takeda Chem Ind Ltd 水性製剤
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
EP0289900A1 (en) * 1987-04-30 1988-11-09 Abbott Laboratories Topical antibacterial compositions

Also Published As

Publication number Publication date
IL93143A0 (en) 1990-11-05
KR910700066A (ko) 1991-03-13
GR900100044A (el) 1991-06-07
WO1990008553A1 (en) 1990-08-09
IE900245L (en) 1990-07-24

Similar Documents

Publication Publication Date Title
GB2243778B (en) Adhesive drug delivery composition
AU3275089A (en) Transdermal drug delivery device
AU5106890A (en) Device for the transdermal delivery of nicotine
EP0431080A4 (en) Compositions and methods for drug delivery and chromatography
AU1917788A (en) Estradiol transdermal delivery system
AU2152688A (en) Dosage form comprising fast agent delivery followed by slow agent delivery
AU2707788A (en) Sustained release pharmaceutical composition
AU4745390A (en) Compositions for transdermal delivery of estradiol
AU4148989A (en) Pharmaceutical compositions
AU3674489A (en) Pharmaceutical compositions
AU8677791A (en) Drug delivery devices
EP0491812A4 (en) Drug delivery compositions
AU5541290A (en) Pharmaceutical compositions
AU2345695A (en) Pharmaceutical composition for transdermal delivery
AU2837089A (en) New indolylpiperidine compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0683668A4 (en) PREPARATIONS AND METHODS FOR TRANSDERMAL DRUG ADMINISTRATION.
AU4918790A (en) Medicament
AU2345988A (en) Pharmaceutical composition for piperidinoalkanol-decongestant combination
AU5041190A (en) Transdermal drug delivery composition
AU6012990A (en) Pharmaceutical formulation
GB2232891B (en) Pharmaceutical composition
EP0443027A4 (en) Drug composition
AU3723589A (en) Therapeutic composition
AU5276690A (en) Pharmaceutical compositions
AU2876889A (en) Pharmaceutical composition for 4-aroylimidazol-2-ones